|
Vol.
25 No. 3
May - June 2003
Where
2B &Y |
|
|
Announcements
of conferences, symposia, workshops, meetings, and other
upcoming activities. |
Therapeutic
Drug Monitoring and Clinical Toxicology
711
September 2003, Basel, Switzerland
The
8th Congress of the International Association of Therapeutic
Drug Monitoring & Clinical Toxicology brings together
an international group of experts who will examine basic concepts
of established and new therapy, recent clinical outcomes in
transplantation, and clinical areas posing particular challenges
for immunosuppression. It is suited to the interests of both
clinicians and laboratory scientists working in the field
of transplantation. A pre-congress symposium, 56 September,
will focus on the clinical use of drugs.
Plenary
lectures at the congress will focus on topics such as transport
proteins and intestinal metabolism, pharmacogenetics/pharmacogenomics
and pharmacotherapy, new aspects in drug substitution therapy,
and how to develop new drugs. Symposia titles are TDM of drugs
in anti-HIV-therapy and other antiviral drugs, indications
of TDM for antidepressants and new generations of neuroleptics,
pharmacogenetics, analytical aspects of immuno- suppressive
drug monitoring on behalf of the IFCC working group, current
knowledge of designer drug toxicity, advances in doping control:
a global challenge, drug facilitated robbery or sexual assault,
toxicogenetics for clinical and forensic toxicology. Workshops,
oral sessions, and breakfast roundtables will also be included.
A
two-day satellite workshop entitled New Advances in Model-Based,
Goal-Oriented Optimal Individualized Drug Therapy: Relationship
To Population PK/PD Modelling and to Multiple Model Methods
for Optimal Tracking of Drug Behavior and Optimal Dosage Design
will be held 1213 September. This course is intended
for physicians, pharmacists, clinical toxicologists, and biomedical
scientists with an interest in population pharmacokinetic
and pharmacodynamic modelling and in therapeutic drug monitoring
and optimal individualization of drug therapy for patient
care.
For
more information contact:
Congress
Plus GmbH
Rosemarie B. Marty
Schwarzwaldallee 215
Postfach CH-4016 Basel, Switzerland
Tel.: 41 61 683 13 82
Fax: 41 61 683 13 83
E-mail:
[email protected]
or [email protected]
www.ictdmct2003.ch
Page
last modified 28 April 2003.
Copyright © 2002-2003 International Union of Pure and
Applied Chemistry.
Questions regarding the website, please contact [email protected]
|